Lebanon vs Uganda: Access to anti-retroviral drugs, male
Lebanon
80.0%
in 2024
Uganda
81.0%
in 2024
Lebanon rank
47th
Uganda rank
46th
Access to anti-retroviral drugs, male over time
- Lebanon
- Uganda
How they compare
Uganda currently reports 81.0% against 80.0% in Lebanon, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Lebanon ahead.
Lebanon ranks 47th and Uganda ranks 46th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 7.6% | 11.5% | Lebanon |
| 2010s | 58.2% | 44.3% | 13.9% | Lebanon |
| 2020s | 82.4% | 75.6% | 6.8% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Lebanon or Uganda?
- Uganda, at 81.0% against 80.0% in Lebanon as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Lebanon and Uganda?
- 1.0%, with Uganda ahead.
- How many years of comparable data are there for Lebanon and Uganda?
- 25 years are reported by both, from 2000 to 2024.
- How do Lebanon and Uganda rank globally for access to anti-retroviral drugs, male?
- Lebanon ranks 47th and Uganda ranks 46th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.